Your browser doesn't support javascript.
loading
Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines.
Botton, Jérémie; Dray-Spira, Rosemary; Baricault, Bérangère; Drouin, Jérôme; Bertrand, Marion; Jabagi, Marie-Joëlle; Weill, Alain; Zureik, Mahmoud.
Afiliação
  • Botton J; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products of the French National Agency for the Safety of Medicines and Health Products and French National Health Insurance, France; Faculté de Pharmacie, Université Paris-Saclay, 92296 Châtenay-Malabry, France. Electronic address: jeremi
  • Dray-Spira R; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products of the French National Agency for the Safety of Medicines and Health Products and French National Health Insurance, France.
  • Baricault B; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products of the French National Agency for the Safety of Medicines and Health Products and French National Health Insurance, France.
  • Drouin J; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products of the French National Agency for the Safety of Medicines and Health Products and French National Health Insurance, France.
  • Bertrand M; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products of the French National Agency for the Safety of Medicines and Health Products and French National Health Insurance, France.
  • Jabagi MJ; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products of the French National Agency for the Safety of Medicines and Health Products and French National Health Insurance, France.
  • Weill A; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products of the French National Agency for the Safety of Medicines and Health Products and French National Health Insurance, France.
  • Zureik M; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products of the French National Agency for the Safety of Medicines and Health Products and French National Health Insurance, France; University Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Anti-infective evasion and Pharmacoepidemiology,
Vaccine ; 40(3): 414-417, 2022 01 24.
Article em En | MEDLINE | ID: mdl-34924220
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article